Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy
Contribution of Indocyanine Green Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy
University Hospital, Brest
242 participants
Jun 22, 2021
INTERVENTIONAL
Conditions
Summary
* Hypoparathyroidism is the most common complication after a total thyroidectomy surgery. It becomes permanent after 6 months. * Untreated permanent hypoparathyroidism is a source of numerous complications in general and therefore requires lifelong replacement therapy resulting in a significant deterioration in quality of life. * The intraoperative use of indocyanine green (ICG) angiography has recently been described as a reliable means of detecting parathyroidism and predicting the risk of postoperative hypoparathyroidism. * This use could prove to be a way to preserve parathyroid in vivo and thus reduce post-operative hypoparathyroidism rates.
Eligibility
Inclusion Criteria3
- Patient having to undergo a total thyroidectomy
- Signed consent
- Patient beneficiary of a social security regimen
Exclusion Criteria8
- Minor patient under 18 years old
- Major patient protected by law or unable to give informed consent
- Pregnant or breastfeeding woman
- Thyroidectomy totalization
- History of thyroid or parathyroid surgery
- Participation refusal
- Known allergy to ICG
- Woman of child-bearing age not using adequate method of contraception
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
During thyroidectomy surgery, the patient will received 2 or 3 injections of 5 mg as a bolus. The first one during the dissection of the first lobe, then during the dissection of the second lobe and finally if needed, a 3rd injection will be done at the end of the dissection. Patients will then be followed during 6 months.
During thyroidectomy surgery, patients are treated according to traditional surgery with detection of parathyroids with the naked eyes. Patients will then be followed during 6 months.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04785443